Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas.
Celik
I
I
Kars
A
A
Güler
N
N
Barişta
I
I
Tekuzman
G
G
Ozyilkan
O
O
Hayran
M
M
Firat
D
D
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D015080:Mesna / Q000008:administration & dosage; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D011446:Prospective Studies; D016896:Treatment Outcome
D005047:Etoposide; D008942:Mitoxantrone; D015080:Mesna; D007069:Ifosfamide